Deferasirox Fe3+ chelate is a novel, oral and potent iron chelator (chelating agent) that was rationally designed.

CA3 (also known as CIL56) is a novel and potent inhibitor of YAP1/Tead transcriptional activity.

CP-24879 hydrochloride (CP24879; p-isopentoxyaniline)) is a novel and potent dual inhibitor of D5D/D6D (delta5 and/or the delta6) fatty acid desaturase with antisteatotic and anti-inflammatory activity.

NADPH tetracyclohexanamine (NADPH; β-NADPH; TPNH), the tetracyclohexanamine salt form of NADPH (β-Nicotinamide adenine dinucleotide phosphate), is a potent cofactor and biological reducing agent, also an electron donor and a cofactor for nitric oxide synthetase.

UAMC-3203 (UAMC3203) is a novel and selective Ferroptosis inhibitor with an IC50 value of 12 nM.

SRS11-92 is a potent ferroptosis inhibitor and a derivative of ferrostatin-1.

UAMC-3203 HCl (UAMC3203 hydrochloride) is a novel, potent, and selective Ferroptosis inhibitor (IC50 value =12 nM) with higher solublility and anti-inflammatory/antioxidant effects.

iFSP1 is a novel and glutathione-independent inhibitor of ferroptosis suppressor protein 1 (FSP1) (AIFM2) with an EC50 of 103 nM.

FIN56 (FIN-56), a specific inducer of ferroptosis, causes the loss of GPX4 activity in cell lysates.

Liproxstatin-1 (Lip-1) is a novel and potent inhibitor of ferroptosis with important biological activity.